Abstract:Background: The African spiny mouse ( Acomys) is an emerging mammalian model for scar-free regeneration, and further study of Acomys could advance the field of regenerative medicine. Isolation of pluripotent stem cells from Acomys would allow for development of transgenic or chimeric animals and in vitro study of regeneration; however, the reproductive biology of Acomys is not well characterized, complicating efforts to derive embryonic stem cells. Thus, we sought to generate Acomys induced pluripotent stem cells (iPSCs) by reprogramming somatic cells back to pluripotency. Methods: To generate Acomys iPSCs, we attempted to adapt established protocols developed in Mus. We utilized a PiggyBac transposon system to genetically modify Acomys fibroblasts to overexpress the Yamanaka reprogramming factors as well as mOrange fluorescent protein under the control of a doxycycline-inducible TetON operon system. Results: Reprogramming factor overexpression caused Acomys fibroblasts to undergo apoptosis or senescence. When SV40 Large T antigen (SV40 LT) was added to the reprogramming cocktail, Acomys cells were able to dedifferentiate into pre-iPSCs. Although use of 2iL culture conditions induced formation of colonies resembling Mus PSCs, these Acomys iPS-like cells lacked pluripotency marker expression and failed to form embryoid bodies. An EOS-GiP system was unsuccessful in selecting for bona fide Acomys iPSCs; however, inclusion of Nanog in the reprogramming cocktail along with 5-azacytidine in the culture medium allowed for generation of Acomys iPSC-like cells with increased expression of several naïve pluripotency markers. Conclusions: There are significant roadblocks to reprogramming Acomys cells, necessitating future studies to determine Acomys-specific reprogramming factor and/or culture condition requirements. The requirement for SV40 LT during Acomys dedifferentiation may suggest that tumor suppressor pathways play an important role in Acomys regeneration and that Acomys may possess unreported cancer resistance.

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency

The Tumor Suppressor Cyld Controls Epithelial Morphogenesis and Homeostasis by Regulating Mitotic Spindle Behavior and Adherens Junction Assembly

CYLD Mediates Ciliogenesis in Multiple Organs by Deubiquitinating Cep70 and Inactivating HDAC6.

The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration

LMCD1 Facilitates the Induction of Pluripotency Via Cell Proliferation, Metabolism, and Epithelial‐mesenchymal Transition

Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.

Inhibition of Syk Promotes Chemical Reprogramming of Fibroblasts Via Metabolic Rewiring and H2 S Production.

Regulation of Natural Killer T-cell Development by Deubiquitinase CYLD

CTCF functions as an insulator for somatic genes and a chromatin remodeler for pluripotency genes during reprogramming

Tet and TDG Mediate DNA Demethylation Essential for Mesenchymal-to-epithelial Transition in Somatic Cell Reprogramming.

CYLD Negatively Regulates Hippo Signaling by Limiting Hpo Phosphorylation in Drosophila.

Cylindromatosis is Required for Survival of a Subset of Melanoma Cells.

TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition

CYLD Deficiency Promotes Pancreatic Cancer Development by Causing Mitotic Defects

CYLD Regulates Angiogenesis by Mediating Vascular Endothelial Cell Migration.

Deubiquitinase CYLD Controls the Plasticity of T-reg Cells by Regulation of Scinderin Expression

Potential Role for the Tumor Suppressor CYLD in Brain and Notochord Development.

Tumor Suppressor Protein CYLD Regulates Morphogenesis of Dendrites and Spines

Tumor suppressors inhibit reprogramming of African spiny mouse ( Acomys) fibroblasts to induced pluripotent stem cells

Deubiquitinating Enzyme CYLD Negatively Regulates the Ubiquitin-Dependent Kinase Tak1 and Prevents Abnormal T Cell Responses

Kinome-wide Functional Analysis Highlights the Role of Cytoskeletal Remodeling in Somatic Cell Reprogramming.